Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Klineova

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cold Spring Harbor Perspectives in Medicine|January 24, 2018
Clinical Course of Multiple SclerosisSylvia Klineova, Fred D Lublin
Ethnicity & Disease|July 7, 2012
Response to disease modifying therapies in African Americans with multiple sclerosisSylvia Klineova, Joyce Nicholas, Aljoeson Walker
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Objective and subjective measures of dalfampridine efficacy in clinical practiceSylvia Klineova, Rebecca Farber, Joshua Friedman, et al.
Multiple Sclerosis and Related Disorders|May 20, 2023
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trialsJacqueline Nicholas, Fred Lublin, Sylvia Klineova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis, et al.
Multiple Sclerosis and Related Disorders|November 18, 2022
Disability outcomes in early-stage African American and White people with multiple sclerosisMaria Petracca, Raffaele Palladino, Amgad Droby, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Black and Non-Hispanic White persons with multiple sclerosis: Social determinants of health and health inequitiesMarta Ponzano, Nicole Graziano, Claire Wigley, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosisSylvia Klineova, Rebecca Farber, Catarina Saiote, et al.
Annals of Clinical and Translational Neurology|February 13, 2026
Structure-Function Decoupling of the Sensorimotor and Default Mode Networks in Black Americans With MSEmilio Cipriano, Giacomo Boffa, Maria Petracca, et al.
Multiple Sclerosis and Related Disorders|August 15, 2021
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)Sylvia Klineova, Asaff Harel, Rebecca Straus Farber, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cold Spring Harbor Perspectives in Medicine|January 24, 2018
Clinical Course of Multiple SclerosisSylvia Klineova, Fred D Lublin
Ethnicity & Disease|July 7, 2012
Response to disease modifying therapies in African Americans with multiple sclerosisSylvia Klineova, Joyce Nicholas, Aljoeson Walker
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Objective and subjective measures of dalfampridine efficacy in clinical practiceSylvia Klineova, Rebecca Farber, Joshua Friedman, et al.
Multiple Sclerosis and Related Disorders|May 20, 2023
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trialsJacqueline Nicholas, Fred Lublin, Sylvia Klineova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis, et al.
Multiple Sclerosis and Related Disorders|November 18, 2022
Disability outcomes in early-stage African American and White people with multiple sclerosisMaria Petracca, Raffaele Palladino, Amgad Droby, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Black and Non-Hispanic White persons with multiple sclerosis: Social determinants of health and health inequitiesMarta Ponzano, Nicole Graziano, Claire Wigley, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosisSylvia Klineova, Rebecca Farber, Catarina Saiote, et al.
Annals of Clinical and Translational Neurology|February 13, 2026
Structure-Function Decoupling of the Sensorimotor and Default Mode Networks in Black Americans With MSEmilio Cipriano, Giacomo Boffa, Maria Petracca, et al.
Multiple Sclerosis and Related Disorders|August 15, 2021
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)Sylvia Klineova, Asaff Harel, Rebecca Straus Farber, et al.
Pageof 3